QXZ-81716-19023
4 vaccinations
4 coded responses
31 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 210 / MD
- Registered
- 2021-11-07
- Relationship
- Child or adolescent in my care
- Guardian
- WLX-14118-65424
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-06
Dose 1 — Pfizer-BioNTech
-
2021-11-07
Registered in v-safe
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-20
-
2021-11-27
Dose 2 — Pfizer-BioNTech
- 2021-11-27
- 2021-11-28
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-11
- 2021-12-20
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-02-26
-
2022-05-21
Dose 3 — Pfizer-BioNTech
- 2022-05-28
- 2022-05-28
- 2022-06-04
- 2022-06-11
- 2022-06-18
- 2022-06-25
-
2022-07-02
Survey response — day 42, dose 3, dependentMedDRA: Cough, Fatigue, Irritability, Ocular hyperaemia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fatigue, coughing, red eyes, irritabilityMedDRA releases: 2024-11 · check-in free text available
- 2022-08-20
-
2022-10-24
Dose 4 — Moderna
-
2022-11-19
Survey response — 6 months, dose 3, dependentMedDRA: Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: They had the same whatever non-COVID sickness the rest of the family had. Fever, cough, fatigue, loss of appetite, congestion, etc. They have since recovered.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-23
Survey response — 3 months, dose 4, dependentMedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-04-24
Survey response — 6 months, dose 4, dependentMedDRA: Hand-foot-and-mouth disease, Headache, Nasopharyngitis, Office visit, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-04-24
Report sent to call center — 6 months, dose 4, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2023-04-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-11-27 | Pfizer-BioNTech | No |
| 3 | 2022-05-21 | Pfizer-BioNTech | No |
| 4 | 2022-10-24 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-24 | Successful 2023-04-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — day 42, dose 3, dependent
Symptoms: Fatigue, coughing, red eyes, irritability
Release 12 — 6 months, dose 3, dependent
Symptoms: They had the same whatever non-COVID sickness the rest of the family had. Fever, cough, fatigue, loss of appetite, congestion, etc. They have since recovered.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release